Use of Time-Saving Flow Cytometry for Rapid Determination of Resistance of Human Cytomegalovirus to Ganciclovir
- 1 October 2005
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 43 (10) , 5003-5008
- https://doi.org/10.1128/jcm.43.10.5003-5008.2005
Abstract
There are two ways to assess the susceptibility of human cytomegalovirus (HCMV) to ganciclovir (GCV): one is a genotypic test that detects resistance-related mutations and the other is a phenotypic test that actually assesses susceptibility. The advantages of genotyping the UL97 gene are its rapidity and accuracy. However, to detect novel mutations or mutations affecting the UL54 DNA polymerase, a phenotypic test such as the plaque reduction assay (PRA) is also required. To avoid the shortcomings of PRA such as its time-consuming nature and labor-intensiveness, we developed a time-saving fluorescence-activated cell sorting (TS-FACS) technique. We obtained a GCV 50% inhibitory concentration (IC 50 ) from five clinical isolates and an HCMV laboratory strain (AD169) and compared the results with those from the PRA. The laboratory strain and three clinical isolates were sensitive to GCV. Although there was a minor discrepancy in the case of one of the three isolates, the GCV IC 50 values obtained by TS-FACS analysis correlated well with the results of the PRA. The remaining two isolates were resistant to GCV; one was GCV resistant due to the mutation M460V, and the GCV IC 50 results obtained by TS-FACS analysis and by PRA were also comparable. The advantages of TS-FACS analysis are the shorter time required, the possibility of automation, and its comparability to PRA, considered the gold standard. Thus, TS-FACS analysis may be useful as an alternative to PRA in the clinic.Keywords
This publication has 23 references indexed in Scilit:
- Antiviral drugs in current clinical usePublished by Elsevier ,2004
- A Standardized Plaque Reduction Assay for Determination of Drug Susceptibilities of Cytomegalovirus Clinical IsolatesAntimicrobial Agents and Chemotherapy, 2000
- Comprehensive Restriction Analysis of the UL97 Region Allows Early Detection of Ganciclovir?Resistant Human Cytomegalovirus in an Immunocompromised ChildThe Journal of Infectious Diseases, 1999
- Ganciclovir resistance and UL97 gene mutations in cytomegalovirus blood isolates from patients with AIDS treated with ganciclovirJournal of Clinical Virology, 1999
- A simplified assay for screening of drug resistance of cell-associated cytomegalovirus strainsJournal of Clinical Virology, 1998
- Cytomegalovirus Retinitis and Viral ResistanceThe Journal of Infectious Diseases, 1998
- FAILURE OF GANCICLOVIR TREATMENT ASSOCIATED WITH SELECTION OF A GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS STRAIN IN A LUNG TRANSPLANT RECIPIENTTransplantation, 1997
- Analysis Of The Ul97 Phosphotransferase Coding Sequence In Clinical Cytomegalovirus Isolates And Identification Of Mutations Conferring Ganciclovir ResistanceThe Journal of Infectious Diseases, 1995
- Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma.Journal of Clinical Investigation, 1995
- Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antiviralsClinical and Diagnostic Virology, 1993